Jump to content
Sclero Forums
Sign in to follow this  
Joelf

Smoking in Systemic Sclerosis (SSc): a Longitudinal European Scleroderma Trials and Research Group Study.

Recommended Posts

Smoking in Systemic Sclerosis (SSc): a Longitudinal European Scleroderma Trials and Research Group Study.

 

The known adverse effect of smoking on bronchial airways and alveoli is observed in SSc patients, but not on the progression of SSc–specific pulmonary or cutaneous manifestations. PubMed, Arthritis Rheumatol, 05/21/2018. (Also see Preventive Care for Pulmonary Involvement)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Board Member

ISN Secretary of the Board

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×